Ceramide and Sphingosine 1-Phosphate in Liver Diseases
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Woo-Jae Park | - |
dc.contributor.author | 송재휘 | - |
dc.contributor.author | 김군태 | - |
dc.contributor.author | 박태식 | - |
dc.date.available | 2020-06-17T03:35:37Z | - |
dc.date.created | 2020-06-03 | - |
dc.date.issued | 2020-05 | - |
dc.identifier.issn | 1016-8478 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/54264 | - |
dc.description.abstract | The liver is an important organ in the regulation of glucose and lipid metabolism. It is responsible for systemic energy homeostasis. When energy need exceeds the storage capacity in the liver, fatty acids are shunted into nonoxidative sphingolipid biosynthesis, which increases the level of cellular ceramides. Accumulation of ceramides alters substrate utilization from glucose to lipids, activates triglyceride storage, and results in the development of both insulin resistance and hepatosteatosis, increasing the likelihood of major metabolic diseases. Another sphingolipid metabolite, sphingosine 1-phosphate (S1P) is a bioactive signaling molecule that acts via S1P-specific G protein coupled receptors. It regulates many cellular and physiological events. Since an increase in plasma S1P is associated with obesity, it seems reasonable that recent studies have provided evidence that S1P is linked to lipid pathophysiology, including hepatosteatosis and fibrosis. Herein, we review recent findings on ceramides and S1P in obesity-mediated liver diseases and the therapeutic potential of these sphingolipid metabolites. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 한국분자세포생물학회 | - |
dc.relation.isPartOf | Molecules and Cells | - |
dc.title | Ceramide and Sphingosine 1-Phosphate in Liver Diseases | - |
dc.title.alternative | Ceramide and Sphingosine 1-Phosphate in Liver Diseases | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000537358700001 | - |
dc.identifier.doi | 10.14348/molcells.2020.0054 | - |
dc.identifier.bibliographicCitation | Molecules and Cells, v.43, no.5, pp.419 - 430 | - |
dc.identifier.kciid | ART002589312 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-85085586135 | - |
dc.citation.endPage | 430 | - |
dc.citation.startPage | 419 | - |
dc.citation.title | Molecules and Cells | - |
dc.citation.volume | 43 | - |
dc.citation.number | 5 | - |
dc.contributor.affiliatedAuthor | Woo-Jae Park | - |
dc.contributor.affiliatedAuthor | 송재휘 | - |
dc.contributor.affiliatedAuthor | 김군태 | - |
dc.contributor.affiliatedAuthor | 박태식 | - |
dc.subject.keywordAuthor | ceramide | - |
dc.subject.keywordAuthor | fibrosis | - |
dc.subject.keywordAuthor | insulin resistance | - |
dc.subject.keywordAuthor | obesity | - |
dc.subject.keywordAuthor | sphingosine 1-phosphate | - |
dc.subject.keywordAuthor | steatosis | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.